검색
Nutriband Inc
NTRB관심 목록에 추가
3.110USD
-0.010-0.34%
종가 08-07 16:00（ET）시세는 15분 지연됩니다
37.81M시가총액
손실P/E TTM
자세한 내용은 Nutriband Inc 회사
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Nutriband Inc 프로필
종목 코드 NTRB
회사 이름Nutriband Inc
상장일Jun 20, 2017
CEOMelnik (Serguei)
직원 수- -
유형Ordinary Share
회계 연도 종료Jun 20
주소121 S Orange Ave Ste 1500
도시ORLANDO
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호32801-3241
전화14073776695
웹사이트https://nutriband.com/
종목 코드 NTRB
상장일Jun 20, 2017
CEOMelnik (Serguei)
Nutriband Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
839.00K
-11.97%
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
13.96K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
Dr. Alan Smith, Ph.D.
Dr. Alan Smith, Ph.D.
Chief Operating Officer, President of 4P Therapeutics
Chief Operating Officer, President of 4P Therapeutics
--
--
Prof. Dr. Stefani C. Mancas
Prof. Dr. Stefani C. Mancas
Independent Director
Independent Director
--
--
Mr. Sergei Glinka
Mr. Sergei Glinka
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
839.00K
-11.97%
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
13.96K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
자주 묻는 질문
Nutriband Inc의 상위 5대 주주는 누구인가요?
Nutriband Inc의 상위 5대 주주는 다음과 같습니다: Mr. Serguei Melnik
Nutriband Inc(NTRB)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Nutriband Inc의 주식을 보유한 기관은 총 45곳이며, 이들이 보유한 주식의 총 가치는 약 579.57K로 전체 발행 주식의 4.77%를 차지합니다. 이는 2025Q4 대비 106153.00 증가한 수치입니다.